Annick Haller
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Lung Cancer Treatments and Mutations 4
- Lung Cancer Diagnosis and Treatment 3
- Oncology 6
- Viral-associated cancers and disorders 2
- Co-authors
- Céline Mascaux (9 shared papers)M. Dusart (5 shared papers)Thierry Berghmans (5 shared papers)Sculier Jp (3 shared papers)Philippe Lothaire (4 shared papers)J.J. Lafitte (2 shared papers)Bradley C. Martin (2 shared papers)A-P Meert (2 shared papers)
- Journals
- European Respiratory Journal (4 papers)British Journal of Cancer (3 papers)Lung Cancer (2 papers)Clinical Infectious Diseases (1 paper)Pediatric and Developmental Pathology (1 paper)
- Partner nations
- BelgiumFranceUnited Kingdom
In The Last Decade
Annick Haller
18 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 75
- Pulmonary and Respiratory Medicine 579
- Cancer Research 253
- Oncology 432
- Molecular Biology 403
- Immunology 92
Countries citing papers authored by Annick Haller
This map shows the geographic impact of Annick Haller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annick Haller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annick Haller more than expected).
Fields of papers citing papers by Annick Haller
This network shows the impact of papers produced by Annick Haller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annick Haller. The network helps show where Annick Haller may publish in the future.
Co-authors
The 25 scholars most cited alongside Annick Haller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 499 | |
| 2 | 2019 | 234 | |
| 3 | 2008 | 119 | |
| 4 | 2006 | 118 | |
| 5 | 2006 | 61 | |
| 6 | 2006 | 48 | |
| 7 | 1995 | 32 | |
| 8 | 2001 | 32 | |
| 9 | 2005 | 17 | |
| 10 | 2008 | 14 | |
| 11 | 2008 | 11 | |
| 12 | 2006 | 10 | |
| 13 | 2009 | 8 | |
| 14 | The correlation of c-erbB-2 oncoprotein and established prognostic factors in human breast cancer. | 2001 | 8 |
| 15 | 2005 | 4 | |
| 16 | 2008 | 4 | |
| 17 | 2005 | 3 | |
| 18 | 2005 | 2 | |
| 19 | COX-2 as prognostic factor in lung cancer: systematic review of the literature with meta-analysis. | 2005 | 0 |
| 20 | 2025 | 0 |
About Annick Haller
Annick Haller is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Pharmacology and Pathology and Forensic Medicine, having authored 20 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cancer Genomics and Diagnostics (2 papers), Viral-associated cancers and disorders (2 papers), RNA modifications and cancer (2 papers), MicroRNA in disease regulation (1 paper), Advanced NMR Techniques and Applications (1 paper) and Gastrointestinal disorders and treatments (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (579 citations), Cancer Research (253 citations), Oncology (432 citations), Molecular Biology (403 citations) and Immunology (92 citations). Annick Haller has collaborated with scholars based in Belgium, France and United Kingdom. Frequent co-authors include Céline Mascaux, M. Dusart, Thierry Berghmans, Sculier Jp, Philippe Lothaire, J.J. Lafitte, Bradley C. Martin, A-P Meert, Marianne Paesmans and Vincent Ninane. Their work appears in journals such as European Respiratory Journal, British Journal of Cancer, Lung Cancer, Clinical Infectious Diseases and Pediatric and Developmental Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.